{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:25:54Z","timestamp":1792801554259,"version":"4.5.0"},"reference-count":468,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a neurodegenerative condition characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) in the midbrain resulting in progressive impairment in cognitive and motor abilities. The physiological and molecular mechanisms triggering dopaminergic neuronal loss are not entirely defined. PD occurrence is associated with various genetic and environmental factors causing inflammation and mitochondrial dysfunction in the brain, leading to oxidative stress, proteinopathy, and reduced viability of dopaminergic neurons. Oxidative stress affects the conformation and function of ions, proteins, and lipids, provoking mitochondrial DNA (mtDNA) mutation and dysfunction. The disruption of protein homeostasis induces the aggregation of alpha-synuclein (\u03b1-SYN) and parkin and a deficit in proteasome degradation. Also, oxidative stress affects dopamine release by activating ATP-sensitive potassium channels. The cholinergic system is essential in modulating the striatal cells regulating cognitive and motor functions. Several muscarinic acetylcholine receptors (mAChR) and nicotinic acetylcholine receptors (nAChRs) are expressed in the striatum. The nAChRs signaling reduces neuroinflammation and facilitates neuronal survival, neurotransmitter release, and synaptic plasticity. Since there is a deficit in the nAChRs in PD, inhibiting nAChRs loss in the striatum may help prevent dopaminergic neurons loss in the striatum and its pathological consequences. The nAChRs can also stimulate other brain cells supporting cognitive and motor functions. This review discusses the cholinergic system as a therapeutic target of cotinine to prevent cognitive symptoms and transition to dementia in PD.<\/jats:p>","DOI":"10.3389\/fnins.2021.665820","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T06:27:25Z","timestamp":1632119245000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson\u2019s Disease"],"prefix":"10.3389","volume":"15","author":[{"given":"Alexandre","family":"Iarkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristhian","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Echeverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch. Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","article-title":"Cognitive decline in Parkinson disease.","volume":"13","author":"Aarsland","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/ejn.13949","article-title":"Cholinergic modulation of striatal microcircuits.","volume":"49","author":"Abudukeyoumu","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0014-2999(99)00570-1","article-title":"Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine.","volume":"383","author":"Acquas","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.neuint.2011.02.009","article-title":"Ethanol-induced modulation of synaptic output from the dorsolateral striatum in rat is regulated by cholinergic interneurons.","volume":"58","author":"Adermark","year":"2011","journal-title":"Neurochem. Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1017\/S1355617719000298","article-title":"Predicting progression to parkinson\u2019s disease dementia using multivariate normative comparisons.","volume":"25","author":"Agelink van Rentergem","year":"2019","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"B7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0006-8993(91)90958-X","article-title":"Effects of nicotinic agonists on the NMDA receptor.","volume":"551","author":"Aizenman","year":"1991","journal-title":"Brain Res."},{"key":"B8","first-page":"1","article-title":"Overview","author":"Akaike","year":"2018","journal-title":"Nicotinic Acetylcholine Receptor Signaling in Neuroprotection"},{"key":"B9","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/mds.27017","article-title":"l-Dopa responsiveness is associated with distinctive connectivity patterns in advanced Parkinson\u2019s disease.","volume":"32","author":"Akram","year":"2017","journal-title":"Mov. Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/mds.21640","article-title":"Transcriptional regulation of mesencephalic dopaminergic neurons: the full circle of life and death.","volume":"23","author":"Alavian","year":"2008","journal-title":"Mov. Disord."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124471","article-title":"MAP\/ERK Signaling in developing cognitive and emotional function and its effect on pathological and neurodegenerative processes.","volume":"21","author":"Albert-Gasco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function.","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"B13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","article-title":"Biology of Parkinson\u2019s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.","volume":"6","author":"Alexander","year":"2004","journal-title":"Dialogues Clin. Neurosci."},{"key":"B14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex.","volume":"9","author":"Alexander","year":"1986","journal-title":"Annu. Rev. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109879","article-title":"Genetic defects in the sphingolipid degradation pathway and their effects on microglia in neurodegenerative disease.","volume":"78","author":"Allende","year":"2021","journal-title":"Cell Signal"},{"key":"B16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.yhbeh.2015.06.010","article-title":"Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females.","volume":"74","author":"Almey","year":"2015","journal-title":"Horm. Behav."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7961","DOI":"10.1007\/s12035-018-1095-8","article-title":"Intranasal cotinine plus krill oil facilitates fear extinction, decreases depressive-like behavior, and increases hippocampal calcineurin a levels in mice.","volume":"55","author":"Alvarez-Ricartes","year":"2018","journal-title":"Mole. Neurobiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00415-014-7591-5","article-title":"Resting-state functional connectivity associated with mild cognitive impairment in Parkinson\u2019s disease.","volume":"262","author":"Amboni","year":"2015","journal-title":"J. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/JPD-160925","article-title":"Dementia predictors in parkinson disease: a validation study.","volume":"7","author":"Anang","year":"2017","journal-title":"J. Parkinsons. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/mds.26956","article-title":"Striato-cortical connections in Parkinson\u2019s and Alzheimer\u2019s diseases: Relation to cognition.","volume":"32","author":"Anderkova","year":"2017","journal-title":"Mov. Disord."},{"key":"B21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-5223(19)39443-7","article-title":"Stanley Kent and accessory atrioventricular connections.","volume":"81","author":"Anderson","year":"1981","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/jnc.12306","article-title":"Novel contribution of cell surface and intracellular M1-muscarinic acetylcholine receptors to synaptic plasticity in hippocampus.","volume":"126","author":"Anisuzzaman","year":"2013","journal-title":"J. Neurochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1126\/science.8023166","article-title":"Effect of the nigrostriatal dopamine system on acquired neural responses in the striatum of behaving monkeys.","volume":"265","author":"Aosaki","year":"","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1111\/j.1447-0594.2010.00588.x","article-title":"Acetylcholine-dopamine balance hypothesis in the striatum: an update.","volume":"10","author":"Aosaki","year":"2010","journal-title":"Geriatr. Gerontol. Int."},{"key":"B25","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1523\/JNEUROSCI.14-06-03969.1994","article-title":"Responses of tonically active neurons in the primate\u2019s striatum undergo systematic changes during behavioral sensorimotor conditioning.","volume":"14","author":"Aosaki","year":"","journal-title":"J. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neuroscience.2017.07.060","article-title":"The role of the intrinsic cholinergic system of the striatum: What have we learned from TAN recordings in behaving animals?","volume":"360","author":"Apicella","year":"2017","journal-title":"Neuroscience"},{"key":"B27","first-page":"467","article-title":"Regulation by histamine H3 receptors of neurotransmitter release in the basal ganglia: implications for Parkinson\u2019s disease pathophysiology.","volume":"148","author":"Aquino-Miranda","year":"2012","journal-title":"Gac. Med. Mex."},{"key":"B28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.physbeh.2012.03.020","article-title":"Cholinergic modulation of food and drug satiety and withdrawal.","volume":"106","author":"Avena","year":"2012","journal-title":"Physiol. Behav."},{"key":"B29","doi-asserted-by":"publisher","first-page":"31466","DOI":"10.1074\/jbc.M201308200","article-title":"Non-steroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein.","volume":"277","author":"Avramovich","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.parkreldis.2009.01.003","article-title":"Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson\u2019s disease.","volume":"15","author":"Aybek","year":"2009","journal-title":"Parkinsonism. Relat. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/mds.23895","article-title":"Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson\u2019s disease.","volume":"27","author":"Ballanger","year":"2012","journal-title":"Mov. Disord."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.neuron.2016.09.006","article-title":"Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline.","volume":"91","author":"Ballinger","year":"2016","journal-title":"Neuron"},{"key":"B33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/0891-5849(90)90152-9","article-title":"Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging?","volume":"8","author":"Bandy","year":"1990","journal-title":"Free Radic. Biol. Med."},{"key":"B34","first-page":"802","article-title":"The pathogenesis of Parkinson\u2019s disease: a new hypothesis.","volume":"87","author":"Barbeau","year":"1962","journal-title":"Can. Med. Assoc. J."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00340","article-title":"Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson\u2019s disease.","volume":"6","author":"Barreto","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2147\/IJN.S95077","article-title":"Microglial AGE-albumin is critical for neuronal death in Parkinson\u2019s disease: a possible implication for theranostics.","volume":"10","author":"Bayarsaikhan","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"B37","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00401-007-0313-7","article-title":"Reduced striatal tyrosine hydroxylase in incidental Lewy body disease.","volume":"115","author":"Beach","year":"2008","journal-title":"Acta Neuropathol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-008-0450-7","article-title":"Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nn.3053","article-title":"Mitochondrial CB(1) receptors regulate neuronal energy metabolism.","volume":"15","author":"Benard","year":"2012","journal-title":"Nat. Neurosci."},{"key":"B40","doi-asserted-by":"crossref","first-page":"8493","DOI":"10.1523\/JNEUROSCI.20-22-08493.2000","article-title":"Intrinsic membrane properties underlying spontaneous tonic firing in neostriatal cholinergic interneurons.","volume":"20","author":"Bennett","year":"2000","journal-title":"J. Neurosci."},{"key":"B41","first-page":"267","article-title":"Altered neurofilament expression does not contribute to Lewy body formation.","volume":"148","author":"Bergeron","year":"1996","journal-title":"Am. J. Pathol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/bs.pmbts.2019.07.009","article-title":"PD and DLB: Brain imaging in Parkinson\u2019s disease and dementia with Lewy bodies.","volume":"165","author":"Berman","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1152\/physrev.00006.2016","article-title":"The Inositol Trisphosphate\/calcium signaling pathway in health and disease.","volume":"96","author":"Berridge","year":"2016","journal-title":"Physiol. Rev."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56090452","article-title":"Anatomical characterization of the human structural connectivity between the pedunculopontine nucleus and globus pallidus via multi-shell multi-tissue tractography.","volume":"2020","author":"Bertino","year":"2020","journal-title":"Medicina"},{"key":"B45","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1124\/pr.119.018440","article-title":"Targeting janus kinases and signal transducer and activator of transcription 3 to treat inflammation, fibrosis, and cancer: rationale, progress, and caution.","volume":"72","author":"Bharadwaj","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","article-title":"Dopamine neuron systems in the brain: an update.","volume":"30","author":"Bjorklund","year":"2007","journal-title":"Trends Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ajpath.2015.10.004","article-title":"Altered mitochondrial dna methylation pattern in alzheimer disease-related pathology and in parkinson disease.","volume":"186","author":"Blanch","year":"2016","journal-title":"Am. J. Pathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bbr.2009.12.048","article-title":"The cholinergic system and Parkinson disease.","volume":"221","author":"Bohnen","year":"2011","journal-title":"Behav. Brain Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.17925\/usn.2011.07.02.100","article-title":"Advances in therapeutic options for gait and balance in parkinson\u2019s disease.","volume":"7","author":"Bohnen","year":"2011","journal-title":"US Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","article-title":"History of falls in Parkinson disease is associated with reduced cholinergic activity.","volume":"73","author":"Bohnen","year":"2009","journal-title":"Neurology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9080768","article-title":"Cotinine and 6-Hydroxy-L-Nicotine reverses memory deficits and reduces oxidative stress in abeta25-35-induced rat model of alzheimer\u2019s disease.","volume":"9","author":"Boiangiu","year":"2020","journal-title":"Antioxidants"},{"key":"B52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/10799890801941889","article-title":"G protein-coupled receptors in and on the cell nucleus: a new signaling paradigm?","volume":"28","author":"Boivin","year":"2008","journal-title":"J. Recept. Signal. Transduct. Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1046\/j.1469-7580.2000.19640527.x","article-title":"Synaptic organisation of the basal ganglia.","volume":"196","author":"Bolam","year":"2000","journal-title":"J. Anat."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2014.00290","article-title":"A mouse model of non-motor symptoms in Parkinson\u2019s disease: focus on pharmacological interventions targeting affective dysfunctions.","volume":"8","author":"Bonito-Oliva","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2011.00006","article-title":"Centrality of striatal cholinergic transmission in Basal Ganglia function.","volume":"5","author":"Bonsi","year":"2011","journal-title":"Front. Neuroanat."},{"key":"B56","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1124\/jpet.108.140897","article-title":"Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson\u2019s disease.","volume":"327","author":"Bordia","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B57","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1124\/jpet.109.162396","article-title":"Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization.","volume":"333","author":"Bordia","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.expneurol.2014.09.015","article-title":"The alpha7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.","volume":"263","author":"Bordia","year":"2015","journal-title":"Exp. Neurol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/ejn.14048","article-title":"Cholinergic control of striatal neurons to modulate L-dopa-induced dyskinesias.","volume":"49","author":"Bordia","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease.","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"B61","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1750-3639.2010.00437.x","article-title":"Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer\u2019s disease.","volume":"21","author":"Bose","year":"2011","journal-title":"Brain Pathol."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01873","article-title":"Cholinergic modulation of type 2 immune responses.","volume":"8","author":"Bosmans","year":"2017","journal-title":"Front. Immunol."},{"key":"B63","doi-asserted-by":"crossref","first-page":"II3","DOI":"10.1007\/PL00007758","article-title":"Pathoanatomy of Parkinson\u2019s disease.","volume":"247","author":"Braak","year":"2000","journal-title":"J. Neurol."},{"key":"B64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0079-6123(08)64021-2","article-title":"Neuropathological hallmarks of alzheimer\u2019s and parkinson\u2019s diseases.","volume":"117","author":"Braak","year":"1998","journal-title":"Prog. Brain Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","article-title":"Cognitive status correlates with neuropathologic stage in Parkinson disease.","volume":"64","author":"Braak","year":"2005","journal-title":"Neurology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0397-17.2018","article-title":"Targeted activation of cholinergic interneurons accounts for the modulation of dopamine by striatal nicotinic receptors.","volume":"5","author":"Brimblecombe","year":"2018","journal-title":"eNeuro"},{"key":"B67","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/S0024-3205(03)00226-1","article-title":"The potential role of cotinine in the cognitive and neuroprotective actions of nicotine.","volume":"72","author":"Buccafusco","year":"2003","journal-title":"Life Sci."},{"key":"B68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1124\/pr.108.000562","article-title":"Nicotinic acetylcholine receptor signalling: roles in Alzheimer\u2019s disease and amyloid neuroprotection.","volume":"61","author":"Buckingham","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease.","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"B70","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","article-title":"Axon degeneration in Parkinson\u2019s disease.","volume":"246","author":"Burke","year":"2013","journal-title":"Exp. Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5498\/wjp.v10.i11.245","article-title":"Best early-onset Parkinson dementia predictor using ensemble learning among Parkinson\u2019s symptoms, rapid eye movement sleep disorder, and neuropsychological profile.","volume":"10","author":"Byeon","year":"2020","journal-title":"World J. Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/s0301-0082(99)00030-1","article-title":"Synaptic transmission in the striatum: from plasticity to neurodegeneration.","volume":"61","author":"Calabresi","year":"","journal-title":"Prog. Neurobiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/s0166-2236(99)01501-5","article-title":"Acetylcholine-mediated modulation of striatal function.","volume":"23","author":"Calabresi","year":"","journal-title":"Trends Neurosci."},{"key":"B74","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/187152711794480483","article-title":"The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders I: Parkinson\u2019s disease.","volume":"10","author":"Campos","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B75","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mds.28404","article-title":"Neuroimaging of Anxiety in Parkinson\u2019s Disease: A Systematic Review.","volume":"36","author":"Carey","year":"2021","journal-title":"Mov. Disord"},{"key":"B76","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1600-0404.1991.tb05014.x","article-title":"Possible mechanisms underlying the special vulnerability of dopaminergic neurons.","volume":"136","author":"Carlsson","year":"1991","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"B77","doi-asserted-by":"crossref","first-page":"s826","DOI":"10.2741\/1158","article-title":"Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson\u2019s disease.","volume":"8","author":"Carvey","year":"2003","journal-title":"Front. Biosci."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-016-0687-9","article-title":"Connectivity changes in parkinson\u2019s disease.","volume":"16","author":"Cerasa","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B79","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.neuroscience.2019.04.008","article-title":"Effects of muscarinic acetylcholine m1 and m4 receptor blockade on dyskinesia in the hemi-parkinsonian rat.","volume":"409","author":"Chambers","year":"2019","journal-title":"Neuroscience"},{"key":"B80","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.mehy.2009.03.053","article-title":"Does smoking reduce the risk of Parkinson\u2019s disease through stimulation of the ubiquitin-proteasome system?","volume":"73","author":"Chapman","year":"2009","journal-title":"Med. Hypotheses"},{"key":"B81","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0006-8993(94)91870-8","article-title":"Brainstem dopaminergic, cholinergic and serotoninergic afferents to the pallidum in the squirrel monkey.","volume":"640","author":"Charara","year":"1994","journal-title":"Brain Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1212\/WNL.0b013e3181d55f38","article-title":"Smoking duration, intensity, and risk of Parkinson disease.","volume":"74","author":"Chen","year":"2010","journal-title":"Neurology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.neuropharm.2005.09.018","article-title":"alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats.","volume":"50","author":"Chen","year":"2006","journal-title":"Neuropharmacology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1212\/WNL.0000000000009431","article-title":"Tobacco smoking and the reduced risk of Parkinson disease: A puzzle of 60 years.","volume":"94","author":"Cheng","year":"2020","journal-title":"Neurology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.parkreldis.2018.02.007","article-title":"Sex differences in progression to mild cognitive impairment and dementia in Parkinson\u2019s disease.","volume":"50","author":"Cholerton","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"B86","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s11682-018-9863-7","article-title":"Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson\u2019s disease patients.","volume":"13","author":"Chondrogiorgi","year":"2019","journal-title":"Brain Imag. Behav."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/hmg\/ddi178","article-title":"Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.","volume":"14","author":"Chung","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1002\/hbm.24631","article-title":"Frontal atrophy as a marker for dementia conversion in Parkinson\u2019s disease with mild cognitive impairment.","volume":"40","author":"Chung","year":"2019","journal-title":"Hum. Brain Mapp."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e2121","DOI":"10.1212\/WNL.0000000000011797","article-title":"Perivascular spaces in the basal ganglia and long-term motor prognosis in newly diagnosed parkinson disease.","volume":"96","author":"Chung","year":"2021","journal-title":"Neurology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/814567","article-title":"Dopaminergic regulation of striatal interneurons in reward and addiction: focus on alcohol.","volume":"2015","author":"Clarke","year":"2015","journal-title":"Neural. Plast."},{"key":"B91","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/JPD-202323","article-title":"Neuropathological and biomarker findings in parkinson\u2019s disease and alzheimer\u2019s disease: from protein aggregates to synaptic dysfunction.","volume":"11","author":"Compta","year":"2021","journal-title":"J. Parkinsons. Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/s0079-6123(08)62400-0","article-title":"D1 and D2 dopamine receptors and the regulation of striatal acetylcholine release in vivo.","volume":"98","author":"Consolo","year":"1993","journal-title":"Prog. Brain Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neubiorev.2018.05.021","article-title":"A new outlook on cholinergic interneurons in Parkinson\u2019s disease and L-DOPA-induced dyskinesia.","volume":"92","author":"Conti","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1093\/brain\/115.6.1701","article-title":"Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson\u2019s disease. A follow-up study of untreated patients.","volume":"115","author":"Cooper","year":"1992","journal-title":"Brain"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7864.1","article-title":"Transporting mitochondria in neurons.","volume":"5","author":"Course","year":"2016","journal-title":"F1000Res"},{"key":"B96","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0306-4522(00)00071-3","article-title":"Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson\u2019s disease and Alzheimer\u2019s disease and in relation to neuroleptic medication.","volume":"98","author":"Court","year":"2000","journal-title":"Neuroscience"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.4103\/1673-5374.300988","article-title":"Dopaminergic-cholinergic imbalance in movement disorders: a role for the novel striatal dopamine D2- muscarinic acetylcholine M1 receptor heteromer.","volume":"16","author":"Crans","year":"2021","journal-title":"Neural. Regen. Res."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150621","article-title":"Associations between anticholinergic burden and adverse health outcomes in parkinson disease.","volume":"11","author":"Crispo","year":"2016","journal-title":"PLoS One"},{"key":"B99","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.tips.2004.04.006","article-title":"Nicotinic acetylcholine receptors and the regulation of neuronal signalling.","volume":"25","author":"Dajas-Bailador","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"B100","first-page":"1064","article-title":"Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors.","volume":"259","author":"Damsma","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B101","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.irn.2015.07.001","article-title":"Neuronal nicotinic acetylcholine receptor structure and function and response to nicotine.","volume":"124","author":"Dani","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15514-3","article-title":"Cholinergic midbrain afferents modulate striatal circuits and shape encoding of action strategies.","volume":"11","author":"Dautan","year":"2020","journal-title":"Nat. Commun."},{"key":"B103","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1523\/JNEUROSCI.5071-13.2014","article-title":"A major external source of cholinergic innervation of the striatum and nucleus accumbens originates in the brainstem.","volume":"34","author":"Dautan","year":"2014","journal-title":"J. Neurosci."},{"key":"B104","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuropharm.2013.03.032","article-title":"Neuroactive effects of cotinine on the hippocampus: behavioral and biochemical parameters.","volume":"71","author":"de Aguiar","year":"2013","journal-title":"Neuropharmacology"},{"key":"B105","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bjp.0707264","article-title":"The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation.","volume":"151","author":"de Jonge","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/mds.26300","article-title":"Striatal cholinergic interneurons and cortico-striatal synaptic plasticity in health and disease.","volume":"30","author":"Deffains","year":"2015","journal-title":"Mov. Disord."},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-00924-7","article-title":"Biological links between traumatic brain injury and Parkinson\u2019s disease.","volume":"8","author":"Delic","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"B108","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1006\/nbdi.2000.0355","article-title":"Parkinson\u2019s disease.","volume":"7","author":"DeLong","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","article-title":"The genetics of Parkinson disease.","volume":"42","author":"Deng","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"B110","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/jnc.13351","article-title":"Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3beta signaling pathway.","volume":"135","author":"Deng","year":"2015","journal-title":"J Neurochem"},{"key":"B111","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B112","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","article-title":"Parkinson disease: from pathology to molecular disease mechanisms.","volume":"62","author":"Dexter","year":"2013","journal-title":"Free Radic Biol. Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0166-2236(94)90005-1","article-title":"Modulatory functions of neurotransmitters in the striatum: ACh\/dopamine\/NMDA interactions.","volume":"17","author":"Di Chiara","year":"1994","journal-title":"Trends Neurosci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.tips.2014.12.002","article-title":"Nicotinic ACh receptors as therapeutic targets in CNS disorders.","volume":"36","author":"Dineley","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"B115","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1101\/lm.025015.111","article-title":"Functional roles of neurotransmitters and neuromodulators in the dorsal striatum.","volume":"20","author":"Do","year":"2012","journal-title":"Learn Mem."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2020.111198","article-title":"Balance alterations and reduction of pedunculopontine cholinergic neurons in early stages of parkinsonism in middle-aged rats.","volume":"145","author":"Dos Santos","year":"2021","journal-title":"Exp. Gerontol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/archneur.1974.00490320001001","article-title":"Human memory and the cholinergic system. A relationship to aging?","volume":"30","author":"Drachman","year":"1974","journal-title":"Arch. Neurol."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0186-8","article-title":"Post translational changes to alpha-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson\u2019s disease.","volume":"12","author":"Duce","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2011.00040","article-title":"Targeting neuronal populations of the striatum.","volume":"5","author":"Durieux","year":"2011","journal-title":"Front. Neuroanat."},{"key":"B120","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2174\/138161282210160304112511","article-title":"Neuroinflammation: a therapeutic target of cotinine for the treatment of psychiatric disorders?","volume":"22","author":"Echeverria","year":"","journal-title":"Curr. Pharm. Des."},{"key":"B121","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pneurobio.2016.01.002","article-title":"Positive modulators of the alpha7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer\u2019s disease.","volume":"144","author":"Echeverria","year":"","journal-title":"Prog. Neurobiol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1755-5949.2012.00317.x","article-title":"Cotinine: a potential new therapeutic agent against Alzheimer\u2019s disease.","volume":"18","author":"Echeverria","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"B123","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3233\/JAD-2011-102136","article-title":"Cotinine reduces amyloid-beta aggregation and improves memory in Alzheimer\u2019s disease mice.","volume":"24","author":"Echeverria","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00086","article-title":"Medications, deep brain stimulation, and other factors influencing impulse control disorders in parkinson\u2019s disease.","volume":"10","author":"Eisinger","year":"2019","journal-title":"Front. Neurol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease.","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord."},{"key":"B126","first-page":"167","article-title":"The effect of nicotine on central catecholamine neurons and gonadotropin secretion. III. Studies on prepubertal female rats treated with pregnant mare serum gonadotropin.","volume":"55","author":"Eneroth","year":"1977","journal-title":"Med. Biol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nn.2984","article-title":"GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons.","volume":"15","author":"English","year":"2011","journal-title":"Nat. Neurosci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1002\/mds.870040502","article-title":"The history of parkinsonism.","volume":"4","author":"Fahn","year":"1989","journal-title":"Mov. Disord."},{"key":"B129","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1085\/jgp.200910345","article-title":"Kinetics of PIP2 metabolism and KCNQ2\/3 channel regulation studied with a voltage-sensitive phosphatase in living cells.","volume":"135","author":"Falkenburger","year":"2010","journal-title":"J. Gen. Physiol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nbd.2004.07.016","article-title":"M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathway.","volume":"17","author":"Farias","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1089\/caff.2019.0008","article-title":"Functional and neuroprotective role of striatal adenosine A2A Receptor Heterotetramers.","volume":"9","author":"Ferre","year":"2019","journal-title":"J. Caffeine Adenosine Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1476-5381.2010.00723.x","article-title":"Adenosine-cannabinoid receptor interactions. Implications for striatal function.","volume":"160","author":"Ferre","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.nbd.2011.10.019","article-title":"Neurochemistry and the non-motor aspects of PD.","volume":"46","author":"Ferrer","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"B134","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00702-010-0482-8","article-title":"Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.","volume":"118","author":"Ferrer","year":"2011","journal-title":"J. Neural. Transm."},{"key":"B135","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.parkreldis.2015.06.009","article-title":"Caregiver report of apathy predicts dementia in Parkinson\u2019s disease.","volume":"21","author":"Fitts","year":"2015","journal-title":"Parkinsonism. Relat. Disord."},{"key":"B136","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/pl00007856","article-title":"The heterogeneity of idiopathic Parkinson\u2019s disease.","volume":"249","author":"Foltynie","year":"","journal-title":"J. Neurol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/jnnp.73.4.363","article-title":"The genetic basis of Parkinson\u2019s disease.","volume":"73","author":"Foltynie","year":"","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B138","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/13803395.2012.753037","article-title":"Mood disturbances and cognitive functioning in Parkinson\u2019s disease: the effects of disease duration and side of onset of motor symptoms.","volume":"35","author":"Foster","year":"2013","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"24403","DOI":"10.1074\/jbc.M115.661827","article-title":"The nicotine metabolite, cotinine, alters the assembly and trafficking of a subset of nicotinic acetylcholine receptors.","volume":"290","author":"Fox","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B140","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/1073858415574600","article-title":"The parkinson disease mitochondrial hypothesis: where are we at?","volume":"22","author":"Franco-Iborra","year":"2016","journal-title":"Neuroscientist"},{"key":"B141","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0166-4328(00)00206-0","article-title":"Smoking and Parkinson\u2019s and Alzheimer\u2019s disease: review of the epidemiological studies.","volume":"113","author":"Fratiglioni","year":"2000","journal-title":"Behav. Brain Res."},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00099","article-title":"A review of the pedunculopontine nucleus in parkinson\u2019s disease.","volume":"10","author":"French","year":"2018","journal-title":"Front. Aging. Neurosci."},{"key":"B143","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.parkreldis.2017.07.013","article-title":"Dementia with lewy bodies and parkinson disease dementia: it is the same disease!","volume":"46","author":"Friedman","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"B144","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s0006-8993(99)01982-4","article-title":"Acute and chronic nicotine exposure differentially facilitate the induction of LTP.","volume":"846","author":"Fujii","year":"1999","journal-title":"Brain Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jphs.2017.05.002","article-title":"Physiological functions of the cholinergic system in immune cells.","volume":"134","author":"Fujii","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"B146","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF01243356","article-title":"Increases in dopamine utilization in certain limbic dopamine terminal populations after a short period of intermittent exposure of male rats to cigarette smoke.","volume":"67","author":"Fuxe","year":"1986","journal-title":"J. Neural. Transm."},{"key":"B147","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0091-3057(79)90319-8","article-title":"On the action of nicotine and cotinine on central 5-hydroxytryptamine neurons.","volume":"10","author":"Fuxe","year":"1979","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B148","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1148\/radiol.2016160274","article-title":"Structural Brain Connectome and Cognitive Impairment in Parkinson Disease.","volume":"283","author":"Galantucci","year":"2017","journal-title":"Radiology"},{"key":"B149","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.neubiorev.2006.11.005","article-title":"From symphony to cacophony: pathophysiology of the human basal ganglia in Parkinson disease.","volume":"32","author":"Gale","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B150","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuint.2019.01.022","article-title":"Disentangling the diverse roles of dopamine D2 receptors in striatal function and behavior.","volume":"125","author":"Gallo","year":"2019","journal-title":"Neurochem. Int."},{"key":"B151","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/ije\/dyy230","article-title":"Exploring causality of the association between smoking and Parkinson\u2019s disease.","volume":"48","author":"Gallo","year":"2019","journal-title":"Int. J. Epidemiol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.bmcl.2014.02.008","article-title":"Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer\u2019s disease.","volume":"24","author":"Gao","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B153","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0173(86)90009-3","article-title":"The basal ganglia and the locomotor regions.","volume":"396","author":"Garcia-Rill","year":"1986","journal-title":"Brain Res."},{"key":"B154","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease.","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch. Neurol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/bpa.12046","article-title":"alpha-Synuclein: the long distance runner.","volume":"23","author":"George","year":"2013","journal-title":"Brain Pathol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","article-title":"Modulation of striatal projection systems by dopamine.","volume":"34","author":"Gerfen","year":"2011","journal-title":"Annu Rev. Neurosci."},{"key":"B157","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.biocel.2014.01.001","article-title":"alpha7 nicotinic acetylcholine receptors control cytochrome c release from isolated mitochondria through kinase-mediated pathways.","volume":"49","author":"Gergalova","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuint.2018.12.003","article-title":"Nicotine protects against manganese and iron-induced toxicity in SH-SY5Y cells: Implication for Parkinson\u2019s disease.","volume":"124","author":"Getachew","year":"2019","journal-title":"Neurochem. Int."},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.578993","article-title":"Interaction of alpha-synuclein with lipids: mitochondrial cardiolipin as a critical player in the pathogenesis of parkinson\u2019s disease.","volume":"14","author":"Gilmozzi","year":"2020","journal-title":"Front. Neurosci."},{"key":"B160","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-642-23274-9_10","article-title":"Muscarinic modulation of striatal function and circuitry.","volume":"208","author":"Goldberg","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuroscience.2011.08.067","article-title":"Spontaneous firing and evoked pauses in the tonically active cholinergic interneurons of the striatum.","volume":"198","author":"Goldberg","year":"2011","journal-title":"Neuroscience"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nyas.12762","article-title":"Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.","volume":"1349","author":"Gonzales","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B163","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors.","volume":"78","author":"Gotti","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00213-010-2153-8","article-title":"Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings.","volume":"215","author":"Graef","year":"2011","journal-title":"Psychopharmacology"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1212\/01.wnl.0000031426.21683.e2","article-title":"Cognitive impairments in advanced PD without dementia.","volume":"59","author":"Green","year":"2002","journal-title":"Neurology"},{"key":"B166","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.parkreldis.2012.07.007","article-title":"Association of nicotine dependence susceptibility gene. CHRNA5, with Parkinson\u2019s disease age at onset: gene and smoking status interaction.","volume":"19","author":"Greenbaum","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"B167","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1007\/s11064-014-1359-2","article-title":"New insights into the mechanisms of action of cotinine and its distinctive effects from nicotine.","volume":"40","author":"Grizzell","year":"2015","journal-title":"Neurochem. Res."},{"key":"B168","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbr.2014.03.047","article-title":"Cotinine reduces depressive-like behavior, working memory deficits, and synaptic loss associated with chronic stress in mice.","volume":"268","author":"Grizzell","year":"2014","journal-title":"Behav. Brain Res."},{"key":"B169","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.pnpbp.2017.05.010","article-title":"Cotinine improves visual recognition memory and decreases cortical Tau phosphorylation in the Tg6799 mice.","volume":"78","author":"Grizzell","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B170","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/0976-3147.143197","article-title":"Psychiatric aspects of Parkinson\u2019s disease.","volume":"6","author":"Grover","year":"2015","journal-title":"J. Neurosci. Rural. Pract."},{"key":"B171","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pneurobio.2018.09.003","article-title":"New insights into the complex role of mitochondria in Parkinson\u2019s disease.","volume":"177","author":"Grunewald","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/mds.27665","article-title":"Modifiable risk factors for cognitive impairment in Parkinson\u2019s disease: a systematic review and meta-analysis of prospective cohort studies.","volume":"34","author":"Guo","year":"2019","journal-title":"Mov. Disord."},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2019.109302","article-title":"High lithium levels in tobacco may account for reduced incidences of both Parkinson\u2019s disease and melanoma in smokers through enhanced beta-catenin-mediated activity.","volume":"131","author":"Guttuso","year":"2019","journal-title":"Med. Hypotheses"},{"key":"B174","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jns.2019.05.016","article-title":"Targeting kinases in Parkinson\u2019s disease: a mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium.","volume":"402","author":"Guttuso","year":"","journal-title":"J. Neurol. Sci."},{"key":"B175","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jns.2019.01.009","article-title":"Could high lithium levels in tobacco contribute to reduced risk of Parkinson\u2019s disease in smokers?","volume":"397","author":"Guttuso","year":"","journal-title":"J. Neurol. Sci."},{"key":"B176","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/jnr.23823","article-title":"Restoring soluble amyloid precursor protein alpha functions as a potential treatment for alzheimer\u2019s disease.","volume":"95","author":"Habib","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660342","article-title":"Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity.","volume":"12","author":"Halder","year":"2021","journal-title":"Front. Immunol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease.","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"B179","doi-asserted-by":"publisher","first-page":"e764","DOI":"10.1212\/WNL.0000000000008995","article-title":"Traumatic brain injury preceding clinically diagnosed alpha-synucleinopathies: A case-control study.","volume":"94","author":"Hasan","year":"2020","journal-title":"Neurology"},{"key":"B180","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0091-3057(97)80001-9","article-title":"Safety of cotinine in humans: physiologic, subjective, and cognitive effects.","volume":"57","author":"Hatsukami","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B181","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.bbr.2010.11.047","article-title":"The cholinergic system and neostriatal memory functions.","volume":"221","author":"Havekes","year":"2011","journal-title":"Behav. Brain Res"},{"key":"B182","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ydbio.2013.04.014","article-title":"Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development.","volume":"379","author":"Hegarty","year":"2013","journal-title":"Dev. Biol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.expneurol.2011.09.035","article-title":"Stress, depression and Parkinson\u2019s disease.","volume":"233","author":"Hemmerle","year":"2012","journal-title":"Exp. Neurol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/WNN.0b013e3181df3048","article-title":"Depression impairs learning whereas anticholinergics impair transfer generalization in Parkinson patients tested on dopaminergic medications.","volume":"23","author":"Herzallah","year":"2010","journal-title":"Cogn. Behav. Neurol."},{"key":"B185","first-page":"728","article-title":"Altered neurofilament expression does not contribute to Lewy body formation.","volume":"149","author":"Hill","year":"1996","journal-title":"Am. J. Pathol."},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61310-w","article-title":"Impairments in face discrimination and emotion recognition are related to aging and cognitive dysfunctions in Parkinson\u2019s disease with dementia.","volume":"10","author":"Ho","year":"2020","journal-title":"Sci. Rep."},{"key":"B187","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.bbapap.2008.09.026","article-title":"Smoking and Parkinson\u2019s disease: does nicotine affect alpha-synuclein fibrillation?","volume":"1794","author":"Hong","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/mds.27002","article-title":"Mild cognitive impairment as a risk factor for Parkinson\u2019s disease dementia.","volume":"32","author":"Hoogland","year":"2017","journal-title":"Mov. Disord"},{"key":"B189","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1089\/ars.2010.3629","article-title":"Single-cell redox imaging demonstrates a distinctive response of dopaminergic neurons to oxidative insults.","volume":"15","author":"Horowitz","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"B190","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neuint.2016.08.009","article-title":"Nicotinic receptor subtypes differentially modulate glutamate release in the dorsal medial striatum.","volume":"100","author":"Howe","year":"2016","journal-title":"Neurochem. Int."},{"key":"B191","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.neuropharm.2010.12.032","article-title":"Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats.","volume":"60","author":"Huang","year":"","journal-title":"Neuropharmacology"},{"key":"B192","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1124\/jpet.111.182949","article-title":"Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2\u2217 nicotinic receptors.","volume":"338","author":"Huang","year":"","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B193","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1471-4159.2009.06011.x","article-title":"Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys.","volume":"109","author":"Huang","year":"2009","journal-title":"J. Neurochem."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.febslet.2015.05.007","article-title":"Regulation of neuronal communication by G protein-coupled receptors.","volume":"589","author":"Huang","year":"2015","journal-title":"FEBS Lett."},{"key":"B195","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1101\/lm.975308","article-title":"Chronic nicotine exposure induces a long-lasting and pathway-specific facilitation of LTP in the amygdala.","volume":"15","author":"Huang","year":"2008","journal-title":"Learn Mem."},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88374-6","article-title":"Whole-brain mapping of monosynaptic inputs to midbrain cholinergic neurons.","volume":"11","author":"Huerta-Ocampo","year":"2021","journal-title":"Sci. Rep."},{"key":"B197","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1017\/cjn.2017.239","article-title":"Nonmotor symptoms of parkinson\u2019s disease as predictors of dementia.","volume":"45","author":"Hussain","year":"2018","journal-title":"Can. J. Neurol. Sci."},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1177\/10738584211011979","article-title":"Non-motor symptoms of parkinson\u2019s disease: the neurobiology of early psychiatric and cognitive dysfunction.","volume":"2021","author":"Hussein","year":"2021","journal-title":"Neuroscientist"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00004","article-title":"Strategies for the treatment of parkinson\u2019s disease: beyond dopamine.","volume":"12","author":"Iarkov","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B200","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/ddr.21294","article-title":"Epigenetic treatment of neurodegenerative disorders: alzheimer and parkinson diseases.","volume":"77","author":"Irwin","year":"2016","journal-title":"Drug Dev. Res."},{"key":"B201","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.neuropharm.2012.11.014","article-title":"Uncoupling of M1 muscarinic receptor\/G-protein interaction by amyloid beta(1-42).","volume":"67","author":"Janickova","year":"2013","journal-title":"Neuropharmacology"},{"key":"B202","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/jnr.23352","article-title":"Downregulation of the Wnt\/beta-catenin signaling pathway is involved in manganese-induced neurotoxicity in rat striatum and PC12 cells.","volume":"92","author":"Jiang","year":"","journal-title":"J. Neurosci. Res."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.neuron.2016.04.028","article-title":"Cholinergic signaling controls conditioned fear behaviors and enhances plasticity of cortical-amygdala circuits.","volume":"90","author":"Jiang","year":"2016","journal-title":"Neuron"},{"key":"B204","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-017-1788-5","article-title":"Parkinson\u2019s disease: experimental models and reality.","volume":"135","author":"Jiang","year":"2018","journal-title":"Acta Neuropathol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12264-013-1406-z","article-title":"M1 muscarinic acetylcholine receptor in Alzheimer\u2019s disease.","volume":"30","author":"Jiang","year":"","journal-title":"Neurosci. Bull."},{"key":"B206","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/mds.27565","article-title":"Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques.","volume":"34","author":"Johnston","year":"2019","journal-title":"Mov. Disord."},{"key":"B207","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1021\/acschemneuro.7b00516","article-title":"Intracellular GPCRs play key roles in synaptic plasticity.","volume":"9","author":"Jong","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B208","doi-asserted-by":"publisher","first-page":"35827","DOI":"10.1074\/jbc.M109.046276","article-title":"Intracellular metabotropic glutamate receptor 5 (mGluR5) activates signaling cascades distinct from cell surface counterparts.","volume":"284","author":"Jong","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B209","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2174\/138161282210160304112133","article-title":"Targeting the nicotinic acetylcholine receptors (nachrs) in astrocytes as a potential therapeutic target in parkinson\u2019s disease.","volume":"22","author":"Jurado-Coronel","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s12035-018-1163-0","article-title":"(E)-Nicotinaldehyde O-cinnamyloxime, a nicotine analog, attenuates neuronal cells death against rotenone-induced neurotoxicity.","volume":"56","author":"Jurado-Coronel","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1124\/mol.58.2.312","article-title":"alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release.","volume":"58","author":"Kaiser","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"B212","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/NEN.0b013e31816362aa","article-title":"Striatal beta-amyloid deposition in Parkinson disease with dementia.","volume":"67","author":"Kalaitzakis","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/JAD-2011-110173","article-title":"Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer\u2019s and Parkinson\u2019s diseases.","volume":"24","author":"Kawamata","year":"2011","journal-title":"J. Alzheimers. Dis."},{"key":"B214","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/2040622310397691","article-title":"Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models.","volume":"2","author":"Kawamata","year":"2011","journal-title":"Ther. Adv. Chronic. Dis."},{"key":"B215","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2174\/138945012800399026","article-title":"alpha7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson\u2019s disease.","volume":"13","author":"Kawamata","year":"2012","journal-title":"Curr. Drug. Targets"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/716871","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease.","volume":"2011","author":"Keane","year":"2011","journal-title":"Parkinsons. Dis."},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2020.100279","article-title":"Cholinergic neurotransmission in the basolateral amygdala during cued fear extinction.","volume":"13","author":"Kellis","year":"2020","journal-title":"Neurobiol. Stress"},{"key":"B218","doi-asserted-by":"publisher","first-page":"13541","DOI":"10.1074\/jbc.M008035200","article-title":"alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity.","volume":"276","author":"Kihara","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B219","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.biomaterials.2015.06.015","article-title":"Transduced PEP-1-PON1 proteins regulate microglial activation and dopaminergic neuronal death in a Parkinson\u2019s disease model.","volume":"64","author":"Kim","year":"2015","journal-title":"Biomaterials"},{"key":"B220","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3988\/jcn.2020.16.3.455","article-title":"Smoking cessation, weight change, and risk of parkinson\u2019s disease: analysis of national cohort data.","volume":"16","author":"Kim","year":"2020","journal-title":"J. Clin. Neurol."},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2019.00010","article-title":"The functional role of striatal cholinergic interneurons in reinforcement learning from computational perspective.","volume":"13","author":"Kim","year":"2019","journal-title":"Front. Neural. Circuits"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28411","article-title":"Genetic and environmental factors in parkinson\u2019s disease converge on immune function and inflammation.","volume":"2020","author":"Kline","year":"2020","journal-title":"Mov. Disord."},{"key":"B223","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/BF02976686","article-title":"Cotinine inhibits catecholamine release evoked by cholinergic stimulation from the rat adrenal medulla.","volume":"26","author":"Koh","year":"2003","journal-title":"Arch. Pharm. Res."},{"key":"B224","doi-asserted-by":"publisher","first-page":"E3159","DOI":"10.1073\/pnas.1605658113","article-title":"Striatal cholinergic interneurons generate beta and gamma oscillations in the corticostriatal circuit and produce motor deficits.","volume":"113","author":"Kondabolu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030656","article-title":"Mechanisms of neurodegeneration in various forms of parkinsonism-similarities and differences.","volume":"10","author":"Koziorowski","year":"2021","journal-title":"Cells"},{"key":"B226","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.neuron.2008.11.005","article-title":"Striatal plasticity and basal ganglia circuit function.","volume":"60","author":"Kreitzer","year":"2008","journal-title":"Neuron"},{"key":"B227","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejphar.2011.09.167","article-title":"Differential effects of subtype-specific nicotinic acetylcholine receptor agonists on early and late hippocampal LTP.","volume":"671","author":"Kroker","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"B228","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrd4295","article-title":"Muscarinic acetylcholine receptors: novel opportunities for drug development.","volume":"13","author":"Kruse","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"B229","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1037\/bne0000048","article-title":"Modeling Parkinson\u2019s disease falls associated with brainstem cholinergic systems decline.","volume":"129","author":"Kucinski","year":"2015","journal-title":"Behav. Neurosci."},{"key":"B230","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/ggi.14156","article-title":"Impact of motor subtype on non-motor symptoms and fall-related features in patients with early Parkinson\u2019s disease.","volume":"21","author":"Kwon","year":"2021","journal-title":"Geriatr. Gerontol. Int."},{"key":"B231","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/WNF.0b013e31827fd9cd","article-title":"Effect of nicotine on the pharmacokinetics of levodopa.","volume":"36","author":"Kyaw","year":"2013","journal-title":"Clin. Neuropharmacol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/bjp.2008.152","article-title":"Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1.","volume":"154","author":"Langmead","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.pharmthera.2007.09.009","article-title":"Muscarinic acetylcholine receptors as CNS drug targets.","volume":"117","author":"Langmead","year":"","journal-title":"Pharmacol. Ther."},{"key":"B234","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1093\/brain\/awy211","article-title":"Can neuroimaging predict dementia in Parkinson\u2019s disease?","volume":"141","author":"Lanskey","year":"2018","journal-title":"Brain"},{"key":"B235","doi-asserted-by":"crossref","first-page":"40398","DOI":"10.1074\/jbc.C500140200","article-title":"Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival.","volume":"280","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B236","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/bph.12973","article-title":"A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson\u2019s disease animal model.","volume":"172","author":"Lee","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1096\/fj.04-1581fje","article-title":"Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons.","volume":"18","author":"Leinninger","year":"2004","journal-title":"FASEB J."},{"key":"B238","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0079-6603(08)60830-2","article-title":"Structural organization and transcription regulation of nuclear genes encoding the mammalian cytochrome c oxidase complex.","volume":"61","author":"Lenka","year":"1998","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/stem.1708","article-title":"Wnt\/beta-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson\u2019s disease.","volume":"32","author":"L\u2019Episcopo","year":"2014","journal-title":"Stem Cells"},{"key":"B240","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1755-5949.2010.00142.x","article-title":"Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders.","volume":"16","author":"Lester","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"B241","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1208\/s12248-009-9090-7","article-title":"Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery.","volume":"11","author":"Lester","year":"2009","journal-title":"AAPS J"},{"key":"B242","first-page":"903","article-title":"Cognitive impairment and dementia in patients with Parkinson disease.","volume":"9","author":"Leverenz","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00424","article-title":"Nicotine bitartrate reduces falls and freezing of gait in parkinson disease: a reanalysis.","volume":"10","author":"Lieberman","year":"2019","journal-title":"Front. Neurol."},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.3389\/fnsyn.2014.00022","article-title":"Striatal cholinergic interneuron regulation and circuit effects.","volume":"6","author":"Lim","year":"2014","journal-title":"Front. Synaptic. Neurosci."},{"key":"B245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047387","article-title":"Non-motor symptoms in patients with Parkinson\u2019s disease - correlations with inflammatory cytokines in serum.","volume":"7","author":"Lindqvist","year":"2012","journal-title":"PLoS One"},{"key":"B246","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0925-4439(99)00029-0","article-title":"In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson\u2019s and Alzheimer\u2019s diseases.","volume":"1454","author":"Linert","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"B247","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41401-020-0380-z","article-title":"Targeting the cholinergic system in Parkinson\u2019s disease.","volume":"41","author":"Liu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.2174\/1386207324666210506152320","article-title":"The molecular mechanism of scutellaria baicalensis georgi stems and leaves flavonoids in promoting neurogenesis and improving memory impairment by the PI3K-AKT-CREB Signaling Pathway in Rats.","volume":"2021","author":"Liu","year":"2021","journal-title":"Comb. Chem. High Throughput Screen"},{"key":"B249","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12264-010-1217-4","article-title":"Modulation of the activity of dopaminergic neurons by SK channels: a potential target for the treatment of Parkinson\u2019s disease?","volume":"26","author":"Liu","year":"2010","journal-title":"Neurosci. Bull."},{"key":"B250","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bcp.2017.05.017","article-title":"Wnt\/beta-catenin signaling plays an essential role in alpha7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson\u2019s disease model.","volume":"140","author":"Liu","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"B251","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bcp.2009.06.004","article-title":"Nicotinic acetylcholine receptors and the ascending dopamine pathways.","volume":"78","author":"Livingstone","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"B252","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3233\/JPD-191672","article-title":"Putaminal dopamine turnover in de novo parkinson\u2019s disease predicts later neuropsychiatric fluctuations but not other major health outcomes.","volume":"9","author":"Lohle","year":"2019","journal-title":"J. Parkinsons. Dis."},{"key":"B253","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1523\/JNEUROSCI.2028-18.2018","article-title":"Inhibition of nigrostriatal dopamine release by striatal GABAA and GABAB Receptors.","volume":"39","author":"Lopes","year":"2019","journal-title":"J. Neurosci."},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0348-20.2020","article-title":"Whole-brain mapping of direct inputs to dopamine D1 and D2 Receptor-expressing medium spiny neurons in the posterior dorsomedial striatum.","volume":"8","author":"Lu","year":"2021","journal-title":"eNeuro"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107391","article-title":"Cholinergic modulation of the immune system - A novel therapeutic target for myocardial inflammation.","volume":"93","author":"Lu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"B256","doi-asserted-by":"publisher","first-page":"447","DOI":"10.14670\/HH-11-944","article-title":"MiRNAs participate in the diagnosis, pathogenesis and therapy of Parkinson\u2019s disease.","volume":"33","author":"Lu","year":"2018","journal-title":"Histol. Histopathol."},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-9-17","article-title":"The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons.","volume":"9","author":"Lu","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"B258","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1113\/jphysiol.2012.241786","article-title":"Direct and GABA-mediated indirect effects of nicotinic ACh receptor agonists on striatal neurones.","volume":"591","author":"Luo","year":"2013","journal-title":"J. Physiol."},{"key":"B259","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.biocel.2014.05.030","article-title":"Mitochondria express several nicotinic acetylcholine receptor subtypes to control various pathways of apoptosis induction.","volume":"53","author":"Lykhmus","year":"2014","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"B260","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1046\/j.1471-4159.1998.71062439.x","article-title":"Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors.","volume":"71","author":"Maggio","year":"1998","journal-title":"J. Neurochem."},{"key":"B261","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1093\/brain\/aww162","article-title":"The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson\u2019s disease.","volume":"139","author":"Maillet","year":"2016","journal-title":"Brain"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.01002","article-title":"Molecular insights into memory-enhancing metabolites of nicotine in brain: a systematic review.","volume":"12","author":"Majdi","year":"2018","journal-title":"Front. Neurosci."},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01488","article-title":"Striatal cholinergic interneurons: how to elucidate their function in health and disease.","volume":"10","author":"Mallet","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B264","doi-asserted-by":"publisher","first-page":"e2132","DOI":"10.1212\/WNL.0000000000009437","article-title":"Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors.","volume":"94","author":"Mappin-Kasirer","year":"2020","journal-title":"Neurology"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123743","article-title":"Wnt\/beta-catenin signaling pathway governs a full program for dopaminergic neuron survival, neurorescue and regeneration in the mptp mouse model of parkinson\u2019s disease.","volume":"19","author":"Marchetti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B266","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1046\/j.0022-3042.2002.00805.x","article-title":"Direct evidence that release-stimulating alpha7\u2217 nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals.","volume":"80","author":"Marchi","year":"2002","journal-title":"J. Neurochem."},{"key":"B267","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1046\/j.1471-4159.1997.68041511.x","article-title":"Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats.","volume":"68","author":"Marshall","year":"1997","journal-title":"J. Neurochem."},{"key":"B268","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1111\/ejn.14741","article-title":"Temporal processing in the striatum: Interplay between midbrain dopamine neurons and striatal cholinergic interneurons.","volume":"53","author":"Martel","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"B269","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1471-4159.2011.07576.x","article-title":"alpha-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases.","volume":"120","author":"Martin","year":"2012","journal-title":"J. Neurochem."},{"key":"B270","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuroscience.2020.11.006","article-title":"Proteomic Complexity in Parkinson\u2019s Disease: A Redox Signaling Perspective of the Pathophysiology and Progression.","volume":"453","author":"Martinez-Banaclocha","year":"2021","journal-title":"Neuroscience"},{"key":"B271","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.1007\/s12035-016-0193-8","article-title":"Relationship between obesity, alzheimer\u2019s disease, and parkinson\u2019s disease: an astrocentric view.","volume":"54","author":"Martin-Jimenez","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106306","article-title":"Minireview: Divergent roles of alpha7 nicotinic acetylcholine receptors expressed on antigen-presenting cells and CD4(+) T cells in the regulation of T cell differentiation.","volume":"82","author":"Mashimo","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"B273","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1016\/S1353-8020(11)70040-2","article-title":"Serotonergic action on dorsal striatal function.","volume":"18","author":"Mathur","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"B274","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.celrep.2015.09.034","article-title":"Striatal Cholinergic interneurons control motor behavior and basal ganglia function in experimental parkinsonism.","volume":"13","author":"Maurice","year":"2015","journal-title":"Cell Rep."},{"key":"B275","doi-asserted-by":"publisher","first-page":"11620","DOI":"10.1073\/pnas.1107748108","article-title":"Striatal origin of the pathologic beta oscillations in Parkinson\u2019s disease.","volume":"108","author":"McCarthy","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.06.013","article-title":"Dopamine deficiency reduces striatal cholinergic interneuron function in models of parkinson\u2019s disease.","volume":"105","author":"McKinley","year":"2019","journal-title":"Neuron"},{"key":"B277","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"alpha-Synuclein misfolding and aggregation: Implications in Parkinson\u2019s disease pathogenesis.","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106434","article-title":"Neurobiological findings underlying depressive behavior in Parkinson\u2019s disease: A review.","volume":"83","author":"Mendonca","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00952","article-title":"Cotinine plus krill oil decreased depressive behavior, and increased astrocytes survival in the hippocampus of mice subjected to restraint stress.","volume":"12","author":"Mendoza","year":"2018","journal-title":"Front. Neurosci."},{"key":"B280","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/cne.903230209","article-title":"Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus.","volume":"323","author":"Mesulam","year":"1992","journal-title":"J. Comp. Neurol."},{"key":"B281","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/cne.902140206","article-title":"Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey.","volume":"214","author":"Mesulam","year":"1983","journal-title":"J. Comp. Neurol."},{"key":"B282","first-page":"97","article-title":"Nicotine and brain disorders.","volume":"21","author":"Mihailescu","year":"2000","journal-title":"Acta Pharmacol. Sin."},{"key":"B283","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00401-008-0439-2","article-title":"Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis\/parkinsonism-dementia complex of Guam (ALS\/PDC).","volume":"116","author":"Miklossy","year":"2008","journal-title":"Acta Neuropathol."},{"key":"B284","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1042\/bst0310869","article-title":"Assembly and subunit diversity of nicotinic acetylcholine receptors.","volume":"31","author":"Millar","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"B285","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuropharm.2008.07.041","article-title":"Diversity of vertebrate nicotinic acetylcholine receptors.","volume":"56","author":"Millar","year":"2009","journal-title":"Neuropharmacology"},{"key":"B286","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2012.00173","article-title":"Cotinine: beyond that expected. more than a biomarker of tobacco consumption.","volume":"3","author":"Moran","year":"2012","journal-title":"Front. Pharmacol."},{"key":"B287","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0079-6123(10)83010-9","article-title":"Pathophysiological roles for purines: adenosine, caffeine and urate.","volume":"183","author":"Morelli","year":"2010","journal-title":"Prog. Brain Res."},{"key":"B288","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1074\/jbc.M110.161489","article-title":"Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway.","volume":"286","author":"Moreno","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B289","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-981-10-8488-1_5","article-title":"Regulation by Nicotinic Acetylcholine Receptors of Microglial Glutamate Transporters: Role of Microglia in Neuroprotection","author":"Morioka","year":"2018","journal-title":"Nicotinic Acetylcholine Receptor Signaling in Neuroprotection"},{"key":"B290","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.neuroscience.2013.11.044","article-title":"Primary cultures of rat cortical microglia treated with nicotine increases in the expression of excitatory amino acid transporter 1 (GLAST) via the activation of the alpha7 nicotinic acetylcholine receptor.","volume":"258","author":"Morioka","year":"2014","journal-title":"Neuroscience"},{"key":"B291","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.lfs.2013.05.013","article-title":"Comparison of subcellular distribution and functions between exogenous and endogenous M1 muscarinic acetylcholine receptors.","volume":"93","author":"Morishima","year":"2013","journal-title":"Life Sci."},{"key":"B292","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00702-006-0561-z","article-title":"Nicotinic receptor agonists as neuroprotective\/neurotrophic drugs. Progress in molecular mechanisms.","volume":"114","author":"Mudo","year":"2007","journal-title":"J. Neural. Transm."},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.07.053","article-title":"Diversity of interneurons in the dorsal striatum revealed by single-cell RNA Sequencing and PatchSeq.","volume":"217","author":"Munoz-Manchado","year":"2018","journal-title":"Cell Rep."},{"key":"B294","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-981-10-8488-1_3","article-title":"A New Aspect of Cholinergic Transmission in the Central Nervous System","author":"Muramatsu","year":"2018","journal-title":"Nicotinic Acetylcholine Receptor Signaling in Neuroprotection"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9010025","article-title":"Two players in the field: hierarchical model of interaction between the dopamine and acetylcholine signaling systems in the striatum.","volume":"9","author":"Myslivecek","year":"2021","journal-title":"Biomedicines"},{"key":"B296","doi-asserted-by":"publisher","first-page":"S443","DOI":"10.33549\/physiolres.933796","article-title":"M(4) muscarinic receptors and locomotor activity regulation.","volume":"66","author":"Myslivecek","year":"2017","journal-title":"Physiol. Res."},{"key":"B297","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neuropharm.2014.10.021","article-title":"The nicotinic cholinergic system function in the human brain.","volume":"96","author":"Nees","year":"2015","journal-title":"Neuropharmacology"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.153951","article-title":"Neuroinflammation disorders exacerbated by environmental stressors.","author":"O\u2019Callaghan","year":"2019","journal-title":"Metabolism"},{"key":"B299","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease.","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7079","article-title":"Complete evaluation of dementia: PET and MRI Correlation and diagnosis for the neuroradiologist.","volume":"2021","author":"Oldan","year":"2021","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"B301","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.conb.2011.04.004","article-title":"Cholinergic modulation of synaptic integration and dendritic excitability in the striatum.","volume":"21","author":"Oldenburg","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"key":"B302","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1124\/jpet.108.136838","article-title":"Cotinine selectively activates a subpopulation of alpha3\/alpha6beta2 nicotinic receptors in monkey striatum.","volume":"325","author":"O\u2019Leary","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B303","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00303","article-title":"Cotinine enhances fear extinction and astrocyte survival by mechanisms involving the nicotinic acetylcholine receptors signaling.","volume":"11","author":"Oliveros-Matus","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B304","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/(SICI)1096-9861(19960318)366:4<580::AID-CNE3<3.0.CO;2-0","article-title":"Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods.","author":"Oorschot","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"B305","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5692\/clinicalneurol.cn-000913","article-title":"A case of successful treatment with donepezil of olfactory hallucination in parkinson disease.","volume":"57","author":"Osada","year":"2017","journal-title":"Rinsho Shinkeigaku"},{"key":"B306","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2021.111273","article-title":"Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson\u2019s disease.","volume":"312","author":"Owens-Walton","year":"2021","journal-title":"Psychiatry Res. Neuroimag."},{"key":"B307","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1523\/JNEUROSCI.3709-06.2007","article-title":"Cholinergic interneurons control the excitatory input to the striatum.","volume":"27","author":"Pakhotin","year":"2007","journal-title":"J. Neurosci."},{"key":"B308","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1247","article-title":"Freezing of gait and dementia in parkinsonism: a retrospective case-control study.","volume":"9","author":"Palermo","year":"","journal-title":"Brain Behav."},{"key":"B309","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3233\/JAD-190323","article-title":"Clinical correlates of cerebral amyloid deposition in parkinson\u2019s disease dementia: evidence from a PET Study.","volume":"70","author":"Palermo","year":"","journal-title":"J. Alzheimers Dis."},{"key":"B310","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108021","article-title":"Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling.","volume":"168","author":"Papke","year":"2020","journal-title":"Neuropharmacology"},{"key":"B311","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0006-8993(03)03195-0","article-title":"Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin.","volume":"984","author":"Parain","year":"2003","journal-title":"Brain Res."},{"key":"B312","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0006-8993(00)03198-X","article-title":"Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice.","volume":"890","author":"Parain","year":"2001","journal-title":"Brain Res."},{"key":"B313","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jchemneu.2011.04.005","article-title":"Serotonin innervation of basal ganglia in monkeys and humans.","volume":"41","author":"Parent","year":"2011","journal-title":"J. Chem. Neuroanat."},{"key":"B314","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1460-9568.2007.05636.x","article-title":"Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action.","volume":"26","author":"Park","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"B315","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00162","article-title":"Cotinine halts the advance of Alzheimer\u2019s disease-like pathology and associated depressive-like behavior in Tg6799 mice.","volume":"6","author":"Patel","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"B316","first-page":"373","article-title":"Pathological changes in dendrites of substantia nigra neurons in Parkinson\u2019s disease: a Golgi study.","volume":"6","author":"Patt","year":"1991","journal-title":"Histol. Histopathol."},{"key":"B317","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/978-3-319-53889-1_19","article-title":"Epigenetics in Parkinson\u2019s Disease.","volume":"978","author":"Pavlou","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"B318","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00441","article-title":"Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration.","volume":"12","author":"Perez","year":"2018","journal-title":"Front. Neurosci."},{"key":"B319","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009332","article-title":"Mitochondrial biology and Parkinson\u2019s disease.","volume":"2","author":"Perier","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B320","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/cne.902380305","article-title":"Immunocytochemical localization of choline acetyltransferase within the rat neostriatum: a correlated light and electron microscopic study of cholinergic neurons and synapses.","volume":"238","author":"Phelps","year":"1985","journal-title":"J. Comp. Neurol."},{"key":"B321","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0893-133X(99)00146-3","article-title":"Nicotinic receptors in the brain. Links between molecular biology and behavior.","volume":"22","author":"Picciotto","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"B322","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuron.2012.08.036","article-title":"Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior.","volume":"76","author":"Picciotto","year":"2012","journal-title":"Neuron"},{"key":"B323","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/138945012800398847","article-title":"alpha7 nicotinic acetylcholine receptor subunit in angiogenesis and epithelial to mesenchymal transition.","volume":"13","author":"Pillai","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"B324","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/sj.npp.1300302","article-title":"Nicotinic acetylcholine receptor distribution in Alzheimer\u2019s disease, dementia with Lewy bodies, Parkinson\u2019s disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.","volume":"29","author":"Pimlott","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B325","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.20-07-j0003.2000","article-title":"Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons.","volume":"20","author":"Pisani","year":"2000","journal-title":"J. Neurosci."},{"key":"B326","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease.","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B327","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2007.02.038","article-title":"Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders.","volume":"563","author":"Pogocki","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"B328","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2174\/1389557520666201117111715","article-title":"Pharmacological Influencing of The Cholinergic Anti-inflammatory pathway in infectious diseases and inflammatory pathologies.","volume":"21","author":"Pohanka","year":"2021","journal-title":"Mini. Rev. Med. Chem."},{"key":"B329","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1073\/pnas.1713129115","article-title":"alpha-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies.","volume":"115","author":"Prots","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B330","doi-asserted-by":"publisher","first-page":"21742","DOI":"10.1074\/jbc.M113.451815","article-title":"alpha-Synuclein oligomers impair neuronal microtubule-kinesin interplay.","volume":"288","author":"Prots","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B331","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-3-7091-6360-3_3","article-title":"Clinical efficacy of budipine in Parkinson\u2019s disease.","volume":"56","author":"Przuntek","year":"1999","journal-title":"J. Neural. Transm. Suppl."},{"key":"B332","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.tins.2004.06.008","article-title":"Smoking, nicotine and Parkinson\u2019s disease.","volume":"27","author":"Quik","year":"2004","journal-title":"Trends Neurosci."},{"key":"B333","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/187152711797247849","article-title":"Targeting nicotinic receptors for Parkinson\u2019s disease therapy.","volume":"10","author":"Quik","year":"2011","journal-title":"CNS Neurol. Disord Drug Targets"},{"key":"B334","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.bcp.2007.06.015","article-title":"Nicotinic receptors as CNS targets for Parkinson\u2019s disease.","volume":"74","author":"Quik","year":"2007","journal-title":"Biochem, Pharmacol."},{"key":"B335","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/bs.irn.2015.07.005","article-title":"Nicotine and Nicotinic Receptor Drugs: Potential for Parkinson\u2019s Disease and Drug-Induced Movement Disorders.","volume":"124","author":"Quik","year":"","journal-title":"Int. Rev. Neurobiol."},{"key":"B336","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.bcp.2013.06.027","article-title":"Multiple CNS nicotinic receptors mediate L-dopa-induced dyskinesias: studies with parkinsonian nicotinic receptor knockout mice.","volume":"86","author":"Quik","year":"","journal-title":"Biochem. Pharmacol."},{"key":"B337","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bcp.2009.05.003","article-title":"Multiple roles for nicotine in Parkinson\u2019s disease.","volume":"78","author":"Quik","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"B338","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0161-813X(02)00036-0","article-title":"Nicotine and nicotinic receptors; relevance to Parkinson\u2019s disease.","volume":"23","author":"Quik","year":"2002","journal-title":"Neurotoxicology"},{"key":"B339","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/mds.25594","article-title":"Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson\u2019s disease.","volume":"28","author":"Quik","year":"","journal-title":"Mov. Disord"},{"key":"B340","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1124\/jpet.105.094375","article-title":"Striatal alpha6\u2217 nicotinic acetylcholine receptors: potential targets for Parkinson\u2019s disease therapy.","volume":"316","author":"Quik","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B341","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1111\/j.1471-4159.2006.04078.x","article-title":"Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates.","volume":"98","author":"Quik","year":"2006","journal-title":"J. Neurochem."},{"key":"B342","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.neuropharm.2012.04.029","article-title":"Role for alpha6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice.","volume":"63","author":"Quik","year":"2012","journal-title":"Neuropharmacology"},{"key":"B343","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1124\/pr.110.003269","article-title":"alpha6beta2\u2217 and alpha4beta2\u2217 nicotinic acetylcholine receptors as drug targets for Parkinson\u2019s disease.","volume":"63","author":"Quik","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"B344","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.bcp.2015.06.014","article-title":"Alpha7 nicotinic receptors as therapeutic targets for Parkinson\u2019s disease.","volume":"97","author":"Quik","year":"","journal-title":"Biochem. Pharmacol."},{"key":"B345","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/00002826-199013003-00008","article-title":"Neurochemical deficits in pathological brain aging: specificity and possible relevance for treatment strategies.","volume":"13","author":"Quirion","year":"1990","journal-title":"Clin. Neuropharmacol."},{"key":"B346","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of alzheimer\u2019s disease neurons.","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J. Alzheimers. Dis."},{"key":"B347","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0197-0186(98)00048-5","article-title":"Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinson\u2019s disease.","volume":"34","author":"Reader","year":"1999","journal-title":"Neurochem. Int."},{"key":"B348","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbamcr.2007.12.003","article-title":"Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells.","volume":"1783","author":"Rehani","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"B349","author":"Rehman","year":"2020","journal-title":"Biochemistry, G Protein Coupled Receptors."},{"key":"B350","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","article-title":"Parkinson\u2019s Disease.","volume":"103","author":"Reich","year":"2019","journal-title":"Med. Clin. North Am."},{"key":"B351","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/gps.4929","article-title":"Visual hallucinations in dementia and Parkinson\u2019s disease: a qualitative exploration of patient and caregiver experiences.","volume":"33","author":"Renouf","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"B352","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.freeradbiomed.2016.04.012","article-title":"Mitochondrial control of cell bioenergetics in Parkinson\u2019s disease.","volume":"100","author":"Requejo-Aguilar","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"B353","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-7-20","article-title":"Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.","volume":"7","author":"Resende","year":"2009","journal-title":"Cell Commun. Signal."},{"key":"B354","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neuro.2008.02.001","article-title":"Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells.","volume":"29","author":"Riveles","year":"2008","journal-title":"Neurotoxicology"},{"key":"B355","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2017.00110","article-title":"Dopamine and Acetylcholine, a Circuit Point of View in Parkinson\u2019s Disease.","volume":"11","author":"Rizzi","year":"2017","journal-title":"Front. Neural. Circuits"},{"key":"B356","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbr.2011.01.055","article-title":"Involvement of the cholinergic system in conditioning and perceptual memory.","volume":"221","author":"Robinson","year":"2011","journal-title":"Behav. Brain Res."},{"key":"B357","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252565","article-title":"Studying the functional connectivity of the primary motor cortex with the binarized cross recurrence plot: The influence of Parkinson\u2019s disease.","volume":"16","author":"Rodriguez-Sabate","year":"2021","journal-title":"PLoS One"},{"key":"B358","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/mds.23179","article-title":"Midbrain SERT in degenerative parkinsonisms: a 123I-FP-CIT SPECT study.","volume":"25","author":"Roselli","year":"2010","journal-title":"Mov. Disord."},{"key":"B359","first-page":"343","article-title":"The evolution and profile of dementia in Parkinson\u2019s disease.","volume":"69","author":"Ross","year":"1996","journal-title":"Adv. Neurol."},{"key":"B360","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41594-019-0252-8","article-title":"Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs.","volume":"26","author":"Roth","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B361","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainresbull.2020.08.010","article-title":"Cotinine ameliorates memory and learning impairment in senescent mice.","volume":"164","author":"Sadigh-Eteghad","year":"2020","journal-title":"Brain Res. Bull."},{"key":"B362","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1007\/s10072-020-04468-5","article-title":"The role of microglia in the development of neurodegeneration.","volume":"41","author":"Saitgareeva","year":"2020","journal-title":"Neurol. Sci."},{"key":"B363","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.1523\/JNEUROSCI.19-18-08145.1999","article-title":"The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal.","volume":"19","author":"Salminen","year":"1999","journal-title":"J. Neurosci."},{"key":"B364","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s40266-016-0416-8","article-title":"Psychosis in parkinson disease: a review of etiology, phenomenology, and management.","volume":"33","author":"Samudra","year":"2016","journal-title":"Drugs Aging"},{"key":"B365","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1515\/revneuro-2016-0068","article-title":"Neurotransmission systems in Parkinson\u2019s disease.","volume":"28","author":"Sanjari Moghaddam","year":"2017","journal-title":"Rev. Neurosci."},{"key":"B366","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215290","article-title":"Understanding G Protein selectivity of muscarinic acetylcholine receptors using computational methods.","volume":"20","author":"Santiago","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B367","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1440-1681.1995.tb01997.x","article-title":"Neuropharmacology of nicotine: effects on the autoregulation of acetylcholine release by substance P and methionine enkephalin in rodent cerebral slices and toxicological implications.","volume":"22","author":"Sastry","year":"1995","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B368","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0304-3940(99)00259-1","article-title":"Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines.","volume":"266","author":"Sato","year":"1999","journal-title":"Neurosci. Lett."},{"key":"B369","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040721","article-title":"GSK-3 and tau: a key duet in alzheimer\u2019s disease.","volume":"10","author":"Sayas","year":"2021","journal-title":"Cells"},{"key":"B370","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2165\/11596310-000000000-00000","article-title":"Monoamine oxidase B inhibitors for the treatment of Parkinson\u2019s disease: a review of symptomatic and potential disease-modifying effects.","volume":"25","author":"Schapira","year":"2011","journal-title":"CNS Drugs"},{"key":"B371","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease.","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov. Disord"},{"key":"B372","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia.","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B373","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3390\/biom5031467","article-title":"Is cell death primary or secondary in the pathophysiology of idiopathic parkinson\u2019s disease?","volume":"5","author":"Schulz-Schaeffer","year":"2015","journal-title":"Biomolecules"},{"key":"B374","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.expneurol.2017.04.008","article-title":"Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson\u2019s disease genes.","volume":"298","author":"Scott","year":"2017","journal-title":"Exp. Neurol."},{"key":"B375","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/mds.24012","article-title":"Environmental tobacco smoke and Parkinson\u2019s disease.","volume":"27","author":"Searles Nielsen","year":"2012","journal-title":"Mov. Disord."},{"key":"B376","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3164\/jcbn.18-25","article-title":"Modification of alpha-synuclein by lipid peroxidation products derived from polyunsaturated fatty acids promotes toxic oligomerization: its relevance to Parkinson disease.","volume":"62","author":"Shamoto-Nagai","year":"2018","journal-title":"J. Clin. Biochem. Nutr."},{"key":"B377","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1007\/s13311-019-00830-4","article-title":"DREADD activation of pedunculopontine cholinergic neurons reverses motor deficits and restores striatal dopamine signaling in parkinsonian rats.","volume":"17","author":"Sharma","year":"2020","journal-title":"Neurotherapeutics"},{"key":"B378","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-981-10-8488-1_8","article-title":"Roles of Nicotinic Acetylcholine Receptors in the Pathology and Treatment of Alzheimer\u2019s and Parkinson\u2019s Diseases","author":"Shimohama","year":"2018","journal-title":"Nicotinic Acetylcholine Receptor Signaling in Neuroprotection"},{"key":"B379","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021203383","article-title":"Cortical thickness from mri to predict conversion from mild cognitive impairment to dementia in parkinson disease: a machine learning-based model.","volume":"2021","author":"Shin","year":"2021","journal-title":"Radiology"},{"key":"B380","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.neuropharm.2017.06.028","article-title":"alpha6beta2 subunit containing nicotinic acetylcholine receptors exert opposing actions on rapid dopamine signaling in the nucleus accumbens of rats with high-versus low-response to novelty.","volume":"126","author":"Siciliano","year":"2017","journal-title":"Neuropharmacology"},{"key":"B381","first-page":"464","article-title":"[The influence of neuromodulators on the synaptic plasticity in dopaminergic structures of the midbrain (hypothetical mechanism)].","volume":"53","author":"Sil\u2019kis","year":"2003","journal-title":"Zh Vyssh Nerv Deiat Im I P Pavlova"},{"key":"B382","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3233\/JIN-170027","article-title":"Sensitivity analysis of discharge patterns of subthalamic nucleus in the model of basal ganglia in Parkinson disease.","volume":"16","author":"Singh","year":"2017","journal-title":"J. Integr. Neurosci."},{"key":"B383","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.2174\/1381612822666160127112914","article-title":"The Role of alpha7 nicotinic acetylcholine receptors and alpha7-specific antibodies in neuroinflammation related to alzheimer disease.","volume":"22","author":"Skok","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"B384","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1124\/mol.64.4.885","article-title":"Functional nicotinic acetylcholine receptors are expressed in B lymphocyte-derived cell lines.","volume":"64","author":"Skok","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"B385","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/ana.24778","article-title":"Physiology of freezing of gait.","volume":"80","author":"Snijders","year":"2016","journal-title":"Ann. Neurol."},{"key":"B386","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/s0006-2952(02)01070-5","article-title":"Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson\u2019s disease.","volume":"64","author":"Soto-Otero","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"B387","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1085\/jgp.201010532","article-title":"Nicotine up-regulates alpha4beta2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning.","volume":"137","author":"Srinivasan","year":"2011","journal-title":"J. Gen. Physiol."},{"key":"B388","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.neurobiolaging.2009.04.015","article-title":"Chronic nicotine restores normal Abeta levels and prevents short-term memory and E-LTP impairment in Abeta rat model of Alzheimer\u2019s disease.","volume":"32","author":"Srivareerat","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B389","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.expneurol.2011.11.023","article-title":"Basal ganglia output to the PPN, a commentary.","volume":"233","author":"Stein","year":"2012","journal-title":"Exp. Neurol."},{"key":"B390","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/s0306-4522(97)00558-7","article-title":"Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation.","volume":"84","author":"Steinberg","year":"1998","journal-title":"Neuroscience"},{"key":"B391","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2021.06.007","article-title":"Relationships and interactions between ionotropic glutamate receptors and nicotinic receptors in the CNS.","volume":"2021","author":"Stone","year":"2021","journal-title":"Neuroscience"},{"key":"B392","doi-asserted-by":"publisher","first-page":"201S","DOI":"10.1016\/0197-0186(92)90239-n","article-title":"In vitro and in vivo acetylcholine release from rat striatum as a functional paradigm of signal transduction via a D-2 dopamine receptor.","volume":"20","author":"Stoof","year":"1992","journal-title":"Neurochem. Int."},{"key":"B393","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease.","volume":"10","author":"Subramaniam","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"B394","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/j.1365-2044.2006.04870.x","article-title":"Nicotinic acetylcholine receptors on basophils and mast cells.","volume":"61","author":"Sudheer","year":"2006","journal-title":"Anaesthesia"},{"key":"B395","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.tins.2007.03.009","article-title":"Multiple hit hypotheses for dopamine neuron loss in Parkinson\u2019s disease.","volume":"30","author":"Sulzer","year":"2007","journal-title":"Trends Neurosci."},{"key":"B396","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neuron.2007.06.023","article-title":"Parkinson\u2019s disease: return of an old prime suspect.","volume":"55","author":"Sulzer","year":"2007","journal-title":"Neuron"},{"key":"B397","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuron.2012.06.028","article-title":"A feud that wasn\u2019t: acetylcholine evokes dopamine release in the striatum.","volume":"75","author":"Surmeier","year":"2012","journal-title":"Neuron"},{"key":"B398","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1179\/1476830511Y.0000000033","article-title":"Cellular and molecular mechanisms of antioxidants in Parkinson\u2019s disease.","volume":"15","author":"Sutachan","year":"2012","journal-title":"Nutr. Neurosci."},{"key":"B399","first-page":"89","article-title":"Viral etiology for Parkinson\u2019s disease\u2013a possible role of influenza A virus infection.","volume":"52","author":"Takahashi","year":"1999","journal-title":"J. Infect. Dis."},{"key":"B400","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106260","article-title":"Roles of nAChR and Wnt signaling in intestinal stem cell function and inflammation.","volume":"81","author":"Takahashi","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"B401","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1600-0404.2010.01327.x","article-title":"Active and passive smoking and risk of Parkinson\u2019s disease.","volume":"122","author":"Tanaka","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"B402","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/ejn.13638","article-title":"Striatal cholinergic interneurons and Parkinson\u2019s disease.","volume":"47","author":"Tanimura","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"B403","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.2174\/1871527313666140917121132","article-title":"Cholinergic system dysfunction and neurodegenerative diseases: cause or effect?","volume":"13","author":"Tata","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B404","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.1523\/JNEUROSCI.5493-07.2008","article-title":"Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson\u2019s disease.","volume":"28","author":"Taverna","year":"2008","journal-title":"J. Neurosci."},{"key":"B405","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0079-6123(06)60001-0","article-title":"Basal ganglia macrocircuits.","volume":"160","author":"Tepper","year":"2007","journal-title":"Prog. Brain. Res."},{"key":"B406","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0006-8993(92)91127-z","article-title":"The pontine parabrachial region mediates some of the descending inhibitory effects of stimulating the anterior pretectal nucleus.","volume":"594","author":"Terenzi","year":"1992","journal-title":"Brain Res."},{"key":"B407","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bcp.2011.12.043","article-title":"The nicotine metabolite, cotinine, attenuates glutamate (n.d.) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats.","volume":"83","author":"Terry","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"B408","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/jpet.114.219881","article-title":"R-(+) and s-(-) isomers of cotinine augment cholinergic responses in vitro and in vivo.","volume":"352","author":"Terry","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B409","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1527-3458.2005.tb00045.x","article-title":"Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition.","volume":"11","author":"Terry","year":"2005","journal-title":"CNS Drug Rev."},{"key":"B410","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1093\/hmg\/ddm159","article-title":"Parkinson\u2019s disease.","volume":"2","author":"Thomas","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"B411","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1124\/jpet.109.160242","article-title":"Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.","volume":"331","author":"Thomas","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B412","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.00812","article-title":"Cotinine and blood pressure levels: variability omitted once again.","volume":"61","author":"Thomopoulos","year":"2013","journal-title":"Hypertension"},{"key":"B413","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1523\/JNEUROSCI.5620-09.2010","article-title":"Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.","volume":"30","author":"Threlfell","year":"2010","journal-title":"J. Neurosci."},{"key":"B414","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2011.00011","article-title":"Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons.","volume":"5","author":"Threlfell","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"B415","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neuron.2012.04.038","article-title":"Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons.","volume":"75","author":"Threlfell","year":"2012","journal-title":"Neuron"},{"key":"B416","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5694\/mja17.00993","article-title":"Non-motor Parkinson disease: new concepts and personalised management.","volume":"208","author":"Titova","year":"2018","journal-title":"Med. J. Aust."},{"key":"B417","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.freeradbiomed.2013.07.042","article-title":"Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism.","volume":"65","author":"Tiwari","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"B418","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.freeradbiomed.2013.07.042","article-title":"Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism.","volume":"65","author":"Tiwari","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"B419","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1042\/bst0311182","article-title":"The anti-apoptotic response of the Gq\/11-coupled muscarinic receptor family.","volume":"31","author":"Tobin","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"B420","first-page":"119","article-title":"Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.","volume":"150","author":"Tompkins","year":"1997","journal-title":"Am. J. Pathol."},{"key":"B421","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1096\/fj.11-182824","article-title":"Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+.","volume":"25","author":"Toulorge","year":"2011","journal-title":"FASEB J."},{"key":"B422","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1523\/JNEUROSCI.4082-10.2011","article-title":"The distinct role of medium spiny neurons and cholinergic interneurons in the D(2)\/A(2)A receptor interaction in the striatum: implications for Parkinson\u2019s disease.","volume":"31","author":"Tozzi","year":"2011","journal-title":"J. Neurosci."},{"key":"B423","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3109\/10715762.2015.1045505","article-title":"Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson\u2019s disease.","volume":"49","author":"Tripathy","year":"2015","journal-title":"Free Radic Res."},{"key":"B424","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neulet.2017.07.009","article-title":"Nicotine facilitates nicotinic acetylcholine receptor targeting to mitochondria but makes them less susceptible to selective ligands.","volume":"656","author":"Uspenska","year":"2017","journal-title":"Neurosci. Lett."},{"key":"B425","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1242\/jcs.148478","article-title":"Intracellular localization of the M1 muscarinic acetylcholine receptor through clathrin-dependent constitutive internalization is mediated by a C-terminal tryptophan-based motif.","volume":"127","author":"Uwada","year":"2014","journal-title":"J. Cell Sci."},{"key":"B426","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1365-2680.1998.18490.x","article-title":"Nicotine-like effects of cotinine on protein kinase C activity and noradrenaline release in bovine adrenal chromaffin cells.","volume":"18","author":"Vainio","year":"1998","journal-title":"J. Auton. Pharmacol."},{"key":"B427","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020230","article-title":"Parkinson\u2019s Disease: Potential Actions of Lithium by Targeting the WNT\/beta-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway.","volume":"10","author":"Vallee","year":"2021","journal-title":"Cells"},{"key":"B428","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.bbr.2009.12.047","article-title":"The cerebrovascular role of the cholinergic neural system in Alzheimer\u2019s disease.","volume":"221","author":"Van Beek","year":"2011","journal-title":"Behav. Brain Res."},{"key":"B429","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hbm.24857","article-title":"GABAergic changes in the thalamocortical circuit in Parkinson\u2019s disease.","volume":"41","author":"van Nuland","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"B430","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.expneurol.2015.02.020","article-title":"Flies with Parkinson\u2019s disease.","volume":"274","author":"Vanhauwaert","year":"2015","journal-title":"Exp. Neurol."},{"key":"B431","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s11064-011-0619-7","article-title":"Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson\u2019s disease.","volume":"37","author":"Venkateshappa","year":"2012","journal-title":"Neurochem. Res."},{"key":"B432","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00381","article-title":"Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson\u2019s Disease.","volume":"12","author":"Videira","year":"2018","journal-title":"Front. Neurosci."},{"key":"B433","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jnc.14698","article-title":"Clinical and neuropathological differences between Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies - current issues and future directions.","volume":"150","author":"Walker","year":"2019","journal-title":"J. Neurochem."},{"key":"B434","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cellsig.2011.08.017","article-title":"Involvement of store-operated calcium signaling in EGF-mediated COX-2 gene activation in cancer cells.","volume":"24","author":"Wang","year":"2012","journal-title":"Cell Signal."},{"key":"B435","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.112319","article-title":"Cornel iridoid glycoside improves cognitive impairment induced by chronic cerebral hypoperfusion via activating PI3K\/Akt\/GSK-3beta\/CREB pathway in rats.","volume":"379","author":"Wang","year":"","journal-title":"Behav. Brain Res."},{"key":"B436","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00429-018-1780-4","article-title":"Medium spiny neurons of the anterior dorsomedial striatum mediate reversal learning in a cell-type-dependent manner.","volume":"224","author":"Wang","year":"2019","journal-title":"Brain Struct. Funct."},{"key":"B437","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023432","article-title":"Association of transferrin G258A and transferrin receptor A82G polymorphisms with the risk of Parkinson disease in certain area.","volume":"99","author":"Wang","year":"","journal-title":"Medicine"},{"key":"B438","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s12264-017-0160-z","article-title":"Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson\u2019s Disease.","volume":"33","author":"Wang","year":"2017","journal-title":"Neurosci. Bull."},{"key":"B439","first-page":"2389","article-title":"Therapeutic approaches to Alzheimer\u2019s disease through stimulating of non-amyloidogenic processing of amyloid precursor protein.","volume":"20","author":"Wang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B440","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/s0196-9781(96)00179-9","article-title":"Nicotine blocks angiotensin II inhibition of LTP in the dentate gyrus.","volume":"17","author":"Wayner","year":"1996","journal-title":"Peptides"},{"key":"B441","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrd2379","article-title":"Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development.","volume":"6","author":"Wess","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"B442","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000480718","article-title":"Pathophysiologic Basis of Movement Disorders.","volume":"33","author":"Wichmann","year":"2018","journal-title":"Prog. Neurol. Surg."},{"key":"B443","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/mds.27741","article-title":"Changing views of the pathophysiology of Parkinsonism.","volume":"34","author":"Wichmann","year":"2019","journal-title":"Mov. Disord."},{"key":"B444","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/jnr.23840","article-title":"Cholinergic regulation of fear learning and extinction.","volume":"95","author":"Wilson","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"B445","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","article-title":"Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence.","volume":"26","author":"Wirdefeldt","year":"2011","journal-title":"Eur. J. Epidemiol."},{"key":"B446","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.bcp.2011.07.067","article-title":"Naturally-expressed nicotinic acetylcholine receptor subtypes.","volume":"82","author":"Wu","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"B447","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2174\/1567205017666200424134311","article-title":"Dangerous Liaisons: Tau Interaction with Muscarinic Receptors.","volume":"17","author":"Wysocka","year":"2020","journal-title":"Curr. Alzheimer Res."},{"key":"B448","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/npp.2011.31","article-title":"Muscarinic receptor occupancy and cognitive impairment: a PET study with [11C](+)3-MPB and scopolamine in conscious monkeys.","volume":"36","author":"Yamamoto","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"B449","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0298-19.2019","article-title":"Differential Nicotinic Modulation of Glutamatergic and GABAergic VTA Microcircuits.","volume":"6","author":"Yan","year":"2019","journal-title":"eNeuro"},{"key":"B450","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1152\/jn.1997.77.2.1003","article-title":"D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway.","volume":"77","author":"Yan","year":"1997","journal-title":"J. Neurophysiol."},{"key":"B451","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000479057","article-title":"Dementia-Predicting Cognitive Risk Score and Its Correlation with Cortical Thickness in Parkinson Disease.","volume":"44","author":"Ye","year":"2017","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B452","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0165-1161(95)90046-2","article-title":"Genotoxicity of nicotine and cotinine in the bacterial luminescence test.","volume":"335","author":"Yim","year":"1995","journal-title":"Mutat. Res."},{"key":"B453","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1096\/fj.03-0078fje","article-title":"The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing.","volume":"17","author":"Yogev-Falach","year":"2003","journal-title":"FASEB J."},{"key":"B454","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00415-019-09297-x","article-title":"Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson\u2019s disease.","volume":"266","author":"Yoo","year":"2019","journal-title":"J. Neurol."},{"key":"B455","doi-asserted-by":"publisher","first-page":"373","DOI":"10.5114\/ceji.2015.54602","article-title":"Role of alpha7 nicotinic receptor in the immune system and intracellular signaling pathways.","volume":"40","author":"Zdanowski","year":"2015","journal-title":"Cent. Eur. J. Immunol."},{"key":"B456","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00109","article-title":"Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.","volume":"10","author":"Zeng","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B457","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0376-8716(00)80003-4","article-title":"Clinical pharmacology of oral cotinine.","volume":"60","author":"Zevin","year":"2000","journal-title":"Drug Alcohol. Depend"},{"key":"B458","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00702-019-01997-y","article-title":"Dopaminergic modulation of striatal function and Parkinson\u2019s disease.","volume":"126","author":"Zhai","year":"2019","journal-title":"J. Neural. Transm."},{"key":"B459","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1124\/jpet.113.207639","article-title":"Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson\u2019s disease.","volume":"347","author":"Zhang","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B460","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010209","article-title":"Phosphorylation Signaling in APP Processing in Alzheimer\u2019s Disease.","volume":"21","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B461","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1007\/s12035-016-9743-3","article-title":"Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson\u2019s Disease.","volume":"54","author":"Zhao","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B462","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1alpha, a potential therapeutic target for early intervention in Parkinson\u2019s disease.","volume":"2","author":"Zheng","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"B463","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1073858402239588","article-title":"Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems.","volume":"9","author":"Zhou","year":"2003","journal-title":"Neuroscientist"},{"key":"B464","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1111\/febs.13081","article-title":"Lithium stimulates human bone marrow derived mesenchymal stem cell proliferation through GSK-3beta-dependent beta-catenin\/Wnt pathway activation.","volume":"281","author":"Zhu","year":"2014","journal-title":"FEBS J."},{"key":"B465","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/157016106777698414","article-title":"Hyperhomocysteinemia in movement disorders: Current evidence and hypotheses.","volume":"4","author":"Zoccolella","year":"2006","journal-title":"Curr. Vasc. Pharmacol."},{"key":"B466","doi-asserted-by":"publisher","first-page":"51","DOI":"10.14336\/AD.2017.0416","article-title":"Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson\u2019s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage.","volume":"9","author":"Zou","year":"2018","journal-title":"Aging Dis."},{"key":"B467","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2019.02.019","article-title":"Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson\u2019s disease.","volume":"126","author":"Ztaou","year":"2019","journal-title":"Neurochem. Int."},{"key":"B468","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jnr.20152","article-title":"Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling.","volume":"77","author":"Zuchner","year":"2004","journal-title":"J. Neurosci. Res."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.665820\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T06:28:23Z","timestamp":1632119303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2021.665820\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":468,"alternative-id":["10.3389\/fnins.2021.665820"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2021.665820","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"article-number":"665820"}}